INTEGRATED BIOPHARMA INC Income (Loss) from Continuing Operations, Per Diluted Share
INTEGRATED BIOPHARMA INC (INBP) reported Income (Loss) from Continuing Operations, Per Diluted Share of -$0.03 per share for the 3-month period ending 2011-12-31, per its 10-Q filed 2012-02-21.
Discontinued › Expense Statement › Operating Expenses
us-gaap:IncomeLossFromContinuingOperationsPerDilutedShare · last filed 2012-02-21
- INTEGRATED BIOPHARMA INC income (loss) from continuing operations, per diluted share for the quarter ending 2011-12-31 was -$0.03.
- INTEGRATED BIOPHARMA INC income (loss) from continuing operations, per diluted share for the quarter ending 2011-09-30 was $0.03.
- INTEGRATED BIOPHARMA INC income (loss) from continuing operations, per diluted share for the quarter ending 2010-12-31 was -$0.03.
- INTEGRATED BIOPHARMA INC income (loss) from continuing operations, per diluted share for the quarter ending 2010-09-30 was -$0.02.
| Period end | Income (Loss) from Continuing Operations, Per Diluted Share 3 month | Income (Loss) from Continuing Operations, Per Diluted Share 6 month |
|---|---|---|
| 2011-12-31 | -$0.03 10-Q · filed 2012-02-21 | $0.00 10-Q · filed 2012-02-21 |
| 2011-09-30 | $0.03 10-Q · filed 2011-11-21 | |
| 2010-12-31 | -$0.03 10-Q · filed 2012-02-21 | -$0.05 10-Q · filed 2012-02-21 |
| 2010-09-30 | -$0.02 10-Q · filed 2011-11-21 |